MedPath
NMPA Approval

Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation, Hard Capsules

H20170391

April 11, 2019

H20170391

Drug Information

茚达特罗格隆溴铵吸入粉雾剂用胶囊

杰润

胶囊剂

每粒含马来酸茚达特罗110μg(以C24H28N2O3计)和格隆溴铵50μg(以C19H28NO3计)

化学药品

April 11, 2019

December 27, 2022

Company Information

Applicant Company

6343 Risch,Switzerland

Manufacturing Company

Schaffhauserstrasse,4332 Stein,Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

茚达特罗格隆溴铵吸入粉雾剂用胶囊 - NMPA 批准文号 | MedPath